Blood filtering for autoimmune long COVID
Part of Infections, Lungs & breathing clinical trials.
This trial tests if filtering certain antibodies from the blood can help people with long COVID who experience post-exertional malaise (PEM) and reduced function. It aims to see if this treatment reduces symptoms and improves daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with long COVID based on WHO criteria.
- You have post-exertional malaise (PEM), meaning your symptoms get worse after physical or mental activity.
- Your function level is between 20% and 70% on the Bell scale (you can do some daily activities but need rest).
- You were generally healthy before getting COVID (able to do all normal activities).
- You do not have certain health problems like serious heart or lung disease, diabetes type 1, or active cancer in the last 5 years.
- You are not currently being treated for a systemic autoimmune disorder with immunosuppressive drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an infusion made from human umbilical cord blood can help people with long COVID (also called post-COVID condition) feel better. It may reduce symptoms by supporting the immune system, though more research is needed.
This trial offers an experimental treatment using umbilical cord blood cells to help people with chronic fatigue from long COVID. The goal is to see if this infusion can reduce fatigue and improve quality of life.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
This study tests whether giving a nasal spray of immunoglobulin (antibodies) helps people with long covid who also have a weakened immune system. It may improve symptoms like fatigue or brain fog.
This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.